• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • Year in Review highlights a 2019 filled with advances in research and clinical care

    Year in Review highlights a 2019 filled with advances in research and clinical care

    November 10, 2019

    Both presenters for the ACR: Year in Review agreed that 2019 was a year where the field of rheumatology exploded, both in clinical updates and basic science research, as more people enter the field and technology helps harness “big data.”

  • Panelists examine mechanisms, manifestations of immune-related adverse events associated with cancer immunotherapy

    Panelists examine mechanisms, manifestations of immune-related adverse events associated with cancer immunotherapy

    November 10, 2019

    The session focused on the clinical manifestations of irAEs associated with cancer immunotherapies, including the molecular pathogenesis, tools that aid early diagnosis and treatment, and shared mechanisms and relationships with primary autoimmune diseases.

  • Vaccination for patients with rheumatic disease can be beneficial, provided proper safeguards are followed

    Vaccination for patients with rheumatic disease can be beneficial, provided proper safeguards are followed

    November 10, 2019

    The risks and benefits of vaccinations for common infectious diseases as well as strategies to risk-stratify patients for PJP and recommend appropriate therapy were reviewed.

  • Identifying markers will help better understand and prevent lupus

    Identifying markers will help better understand and prevent lupus

    November 10, 2019

    “Historically, we’ve thought about how we better treat (lupus), how we make patients feel better … But if we want to eliminate lupus, we need to understand early events and how we can stop things before it’s too late,” said Judith James, MD, PhD.

  • ARP past president offers insights for career development, “paying it forward”

    ARP past president offers insights for career development, “paying it forward”

    November 10, 2019

    Marian T. Hannan, DSc, MPH, encouraged the audience to cultivate their leadership skills and take care of themselves and their careers so that they can best take care of others.

  • Q&A: Incoming ACR President Ellen Gravallese, MD

    Q&A: Incoming ACR President Ellen Gravallese, MD

    November 10, 2019

    “I would suggest that our members demonstrate their enthusiasm for the field and reach out to young students and trainees — the younger they are when we reach out to them, the better. Medical school would be a great time. There’s nothing more important than…

  • NAFLD becomes a growing concern in rheumatology

    NAFLD becomes a growing concern in rheumatology

    November 10, 2019

    NAFLD is approaching epidemic proportions in the United States, and some of the most commonly used rheumatologic agents can cause or contribute to the worsening of liver disease.

  • Keynote speaker uses humor to highlight importance of taking risks in science

    Keynote speaker uses humor to highlight importance of taking risks in science

    November 10, 2019

    David L. Hu, PhD, reminisced about several of his “silly” research projects, illustrating that there are no bad questions — even seemingly silly or unimportant research can be useful.

  • Embracing medical apps could benefit both patients and research efforts

    Embracing medical apps could benefit both patients and research efforts

    November 10, 2019

    The rapidly changing world of medical apps has made for some exciting breakthroughs, but generally, the rheumatology community hasn’t seen as many of these advances because it has been slower to adopt these technologies.

  • Outlook for treating metabolic bone disease improves

    Outlook for treating metabolic bone disease improves

    November 10, 2019

    Approaches and treatments for the metabolic bone disorders rheumatologists are most likely to see, hypophosphatasia, osteomalacia, and primary hyperthyroidism, are changing, and the outlook on all three is improving.

1 2 3
Next Page

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy